QC
AGIO icon

Quadrature Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Quadrature Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+28,111
New +$853K 0.01% 722
2026
Q1 		– Sell
-35,857
Closed -$976K – 1327
2025
Q4 		$976K Buy
+35,857
New +$1.26M 0.01% 526

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Quadrature Capital's AGIO Position: Q2 2026 in Review

Quadrature Capital opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 28,111 shares worth $1.04M. The stake represents 0.01% of the portfolio and ranks #722 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in AGIO as recently as Q4 2025.

Quadrature Capital first reported a position in AGIO in Q4 2025 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Quadrature Capital held 28,111 shares of Agios Pharmaceuticals worth $1.04M as of Q2 2026.
  • Agios Pharmaceuticals was a new Quadrature Capital position in Q2 2026.
  • Agios Pharmaceuticals made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #722 holding.
  • Quadrature Capital first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.